Navigation Links
Know your drugs: A primer for chemical and life science professionals is ACS Webinars topic
Date:3/22/2011

WASHINGTON, March 21, 2011 The modern drug discovery process is the topic of the next in a series of American Chemical Society (ACS) Webinars for scientists and chemical professionals.

Scheduled for Thursday, March 24, from 2 3 p.m., EDT, the free webinar features Terry Kenakin, a Director of Platform Technology Sciences at GlaxoSmithKline Research and Development in Research Triangle Park, North Carolina.

Participants will learn:

  • Stages of the modern drug discovery process
  • How pharmacokinetics and pharmacodynamics are used to guide discovery
  • The primary assays used in discovery and development to guide optimization of efficacy and PK properties, what these assays give you, and how to interpret the data

Kenakin earned his B.S. in chemistry and Ph.D. in pharmacology at the University of Alberta, Canada. After three years at University College, London, UK, he joined Burroughs-Wellcome as a senior research pharmacologist. He then joined GlaxoSmithKline. Kenakin is the author of eight books on pharmacology including most recently, A Pharmacology Primer, Third Edition: Theory, Application and Methods. He is co-editor-in-chief of the International Journal of Receptors and Signal Transduction and Current Opinion in Pharmacology.


'/>"/>

Contact: Nancy McCormick-Pickett
n_mccormick-pickett@acs.org
202-872-4381
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Too Few Get Needed Rheumatoid Arthritis Drugs: Study
2. Heart Risks the Same With 2 Diabetes Drugs: Study
3. A primer on aspirating breast lumps
4. Plastics Chemical Affects U.S. More Than Canada: Study
5. Latest American Chemical Society podcast: Dont blame the pill for estrogen in drinking water
6. Worlds first chemical guided missile could be the answer to wiping out cancer
7. Study Links MS to Brain Chemical Deficiency
8. Naturally occurring brain signaling chemical may be useful in understanding Parkinsons
9. American Chemical Society unveils International Year of Chemistry virtual journal
10. Fat associated with chemical changes in DNA that may help explain obesity-related disease
11. Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... PR ... an upcoming case studies guidebook. This guidebook offers an excellent branding and exposure ... include articles, case studies and how-to’s that fall into the following categories:, ...
(Date:6/27/2017)... ... , ... Dr. Richard Amato, a respected periodontist in Monroe, CT, ... Implant Center of Connecticut. As part of the renovation, the cutting-edge practice added two ... to improve patient comfort while making it possible for Dr. Amato to provide even ...
(Date:6/27/2017)... North Hollywood, CA (PRWEB) , ... June 27, ... ... on orthodontic treatments . Orthodontics is a dental specialty that focuses on ... other appliances. Benefits include improved aesthetics and function. , North Hollywood ...
(Date:6/26/2017)... ... June 26, 2017 , ... Torrance dentist, Dr. Robert ... be one of the most noticeable aspects of a person’s appearance. A healthy, radiant ... is born with beautiful, balanced teeth, everyone can have the smile of their dreams ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced ... hiring of Richard Robinson as chief operating officer (COO). In this role, Robinson ... proven track record of simplifying business processes and developing growth strategies to increase ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: